EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
41 hedge funds and large institutions have $64.9M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $494K
Holders
41
Holding in Top 10
–
Calls
–
Puts
$494K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$796K | |
| 3 | +$386K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$376K |
| 5 |
CCM
Consonance Capital Management
New York
|
+$345K |
Top Sellers
| 1 | -$724K | |
| 2 | -$393K | |
| 3 | -$304K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$230K |
| 5 |
Jennison Associates
New York
|
-$217K |